Bih‐Rong Wei

511 total citations
17 papers, 316 citations indexed

About

Bih‐Rong Wei is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Bih‐Rong Wei has authored 17 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Immunology. Recurrent topics in Bih‐Rong Wei's work include Melanoma and MAPK Pathways (3 papers), Pregnancy and preeclampsia studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Bih‐Rong Wei is often cited by papers focused on Melanoma and MAPK Pathways (3 papers), Pregnancy and preeclampsia studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Bih‐Rong Wei collaborates with scholars based in United States. Bih‐Rong Wei's co-authors include R. Mark Simpson, Glenn Merlino, Helen Michael, Hibret A. Adissu, Belén Hernández, Matthew D. Hall, Michael M. Gottesman, Richard J. Simpson, Neal S. Rote and Jennifer E. Dwyer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and Scientific Reports.

In The Last Decade

Bih‐Rong Wei

17 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bih‐Rong Wei United States	9	151	93	88	51	49	17	316
Jose J. Galvez United States	9	179 1.2×	90 1.0×	128 1.5×	36 0.7×	51 1.0×	16	351
Sibylle Gündisch Germany	11	261 1.7×	22 0.2×	71 0.8×	41 0.8×	30 0.6×	12	387
Georgia Kontostathi Greece	13	195 1.3×	23 0.2×	34 0.4×	70 1.4×	31 0.6×	17	342
C. Cerni Austria	11	237 1.6×	13 0.1×	108 1.2×	67 1.3×	58 1.2×	30	381
G. J. Beattie United Kingdom	6	140 0.9×	29 0.3×	108 1.2×	35 0.7×	12 0.2×	11	326
Morassa Mohseni United States	8	231 1.5×	41 0.4×	101 1.1×	17 0.3×	73 1.5×	8	382
Cory L. Painter United States	10	278 1.8×	83 0.9×	190 2.2×	21 0.4×	29 0.6×	15	470
Tomoko Ueda Japan	9	167 1.1×	24 0.3×	57 0.6×	19 0.4×	16 0.3×	23	310
Yu‐De Chu Taiwan	14	239 1.6×	45 0.5×	65 0.7×	51 1.0×	28 0.6×	48	482

Countries citing papers authored by Bih‐Rong Wei

Since Specialization

Citations

This map shows the geographic impact of Bih‐Rong Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bih‐Rong Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bih‐Rong Wei more than expected).

Fields of papers citing papers by Bih‐Rong Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bih‐Rong Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bih‐Rong Wei. The network helps show where Bih‐Rong Wei may publish in the future.

Co-authorship network of co-authors of Bih‐Rong Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Bih‐Rong Wei. A scholar is included among the top collaborators of Bih‐Rong Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bih‐Rong Wei. Bih‐Rong Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Cero, Cheryl, John S. House, Dereje D. Jima, et al.. (2024). Profiling the cancer-prone microenvironment in a zebrafish model for MPNST. Oncogene. 44(3). 179–191. 2 indexed citations

Wei, Bih‐Rong, et al.. (2022). Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs. Frontiers in Veterinary Science. 9. 1056408–1056408. 4 indexed citations

Wei, Bih‐Rong, Shelley Hoover, Cody J. Peer, et al.. (2020). Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma. Molecular Cancer Therapeutics. 19(11). 2308–2318. 15 indexed citations

Simpson, R. Mark, Shelley Hoover, Barbara J. Davis, et al.. (2020). Inter-Institutional Partnerships to Develop Veterinarian–Investigators through the NIH Comparative Biomedical Scientist Training Program Benefit One Health Goals. Journal of Veterinary Medical Education. 47(5). 619–631. 2 indexed citations

Ye, Xiaoying, Brian T. Luke, Bih‐Rong Wei, et al.. (2018). Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics. Oncotarget. 9(41). 26431–26452. 6 indexed citations

Hernández, Belén, Hibret A. Adissu, Bih‐Rong Wei, et al.. (2018). Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas. International Journal of Molecular Sciences. 19(2). 394–394. 81 indexed citations

Kumar, Jeyan S., Bih‐Rong Wei, James P. Madigan, et al.. (2016). Bioluminescent imaging of ABCG2 efflux activity at the blood-placenta barrier. Scientific Reports. 6(1). 20418–20418. 8 indexed citations

Wei, Bih‐Rong, Helen Michael, Charles Halsey, et al.. (2016). Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma. Pigment Cell & Melanoma Research. 29(6). 643–655. 36 indexed citations

Bakhsheshian, Joshua, Bih‐Rong Wei, Matthew D. Hall, Richard J. Simpson, & Michael M. Gottesman. (2016). In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood–Brain Barrier. Methods in molecular biology. 1461. 227–239. 6 indexed citations

10.

Wei, Bih‐Rong, James P. Madigan, Matthew D. Hall, et al.. (2014). The Protein Phosphatase 2A Inhibitor LB100 Sensitizes Ovarian Carcinoma Cells to Cisplatin-Mediated Cytotoxicity. Molecular Cancer Therapeutics. 14(1). 90–100. 39 indexed citations

11.

Wei, Bih‐Rong & R. Mark Simpson. (2013). Digital pathology and image analysis augment biospecimen annotation and biobank quality assurance harmonization. Clinical Biochemistry. 47(4-5). 274–279. 19 indexed citations

12.

Bakhsheshian, Joshua, Bih‐Rong Wei, Suneet Shukla, et al.. (2013). Bioluminescent imaging of drug efflux at the blood–brain barrier mediated by the transporter ABCG2. Proceedings of the National Academy of Sciences. 110(51). 20801–20806. 35 indexed citations

13.

Wei, Bih‐Rong, et al.. (2012). Increased resistance to apoptosis during differentiation and syncytialization of BeWo choriocarcinoma cells. Advances in Bioscience and Biotechnology. 3(6). 805–813. 8 indexed citations

14.

Webster, Joshua D., Aleksandra M. Michalowski, Jennifer E. Dwyer, et al.. (2012). Investigation into diagnostic agreement using automated computer-assisted histopathology pattern recognition image analysis. Journal of Pathology Informatics. 3(1). 18–18. 14 indexed citations

15.

Wei, Bih‐Rong, R. Mark Simpson, Donald J. Johann, et al.. (2012). Proteomic Profiling of H-Ras-G12V Induced Hypertrophic Cardiomyopathy in Transgenic Mice Using Comparative LC-MS Analysis of Thin Fresh-Frozen Tissue Sections. Journal of Proteome Research. 11(3). 1561–1570. 11 indexed citations

16.

Rote, Neal S., Bih‐Rong Wei, Chuang Xu, & Liping Luo. (2010). Caspase 8 and Human Villous Cytotrophoblast Differentiation. Placenta. 31(2). 89–96. 27 indexed citations

17.

Wei, Bih‐Rong, Jennifer B. Edwards, Shelley Hoover, et al.. (2008). Altered β-Catenin Accumulation in Hepatocellular Carcinomas of Diethylnitrosamine-Exposed Rhesus Macaques. Toxicologic Pathology. 36(7). 972–980. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact